Lion Biotechnologies' Lead Program With National Cancer Institute Demonstrates Positive Results in Patients With Stage 4 Metastatic Melanoma Read more about Lion Biotechnologies' Lead Program With National Cancer Institute Demonstrates Positive Results in Patients With Stage 4 Metastatic Melanoma
Lion Biotechnologies Appoints Dr. Laszlo Radvanyi as Chief Scientific Officer Read more about Lion Biotechnologies Appoints Dr. Laszlo Radvanyi as Chief Scientific Officer
Lion Biotechnologies to Present at the Jefferies 2014 Global Healthcare Conference Read more about Lion Biotechnologies to Present at the Jefferies 2014 Global Healthcare Conference
Lion Biotechnologies Leases New Research Laboratory Read more about Lion Biotechnologies Leases New Research Laboratory
Lion Biotechnologies Announces Exclusive License Agreement With Moffitt Cancer Center Read more about Lion Biotechnologies Announces Exclusive License Agreement With Moffitt Cancer Center
Lion Biotechnologies Enters Clinical Trial Grant Agreement With Moffitt Cancer Center Read more about Lion Biotechnologies Enters Clinical Trial Grant Agreement With Moffitt Cancer Center
Lion Biotechnologies' Chief Scientific Officer to Present at Immunotherapies and Vaccines Summit Read more about Lion Biotechnologies' Chief Scientific Officer to Present at Immunotherapies and Vaccines Summit
Lion Biotechnologies Names Elma Hawkins President and Chief Operating Officer Read more about Lion Biotechnologies Names Elma Hawkins President and Chief Operating Officer
Lion Biotechnologies to Present at the Rodman & Renshaw 16th Annual Global Investment Conference Read more about Lion Biotechnologies to Present at the Rodman & Renshaw 16th Annual Global Investment Conference
Lion Biotechnologies CSO Laszlo Radvanyi Co-Authors Study in Journal of Immunotherapy Read more about Lion Biotechnologies CSO Laszlo Radvanyi Co-Authors Study in Journal of Immunotherapy